These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1365486)

  • 1. Therapeutic activity, clinical and gastric tolerance of 20mg daily dose of droxicam in comparison with piroxicam in patients with degenerative joint disease.
    Schüetz E; Sánchez J; García-Barbal J; Sarti JF; Reuter C; Harrison FJ
    Eur J Rheumatol Inflamm; 1991; 11(4):21-8. PubMed ID: 1365486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial comparing a new NSAID (droxicam) and piroxicam in spinal osteoarthritis.
    Bohl D; Gausmann H; Vorberg G; Sánchez J; García-Barbal R; Sarti JF; Harrison FJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):416-9. PubMed ID: 2258250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, randomized and parallel comparison between droxicam and diclofenac sodium in patients with coxarthrosis and gonarthrosis.
    Corts Giner JR; García Borrás JJ
    Eur J Rheumatol Inflamm; 1991; 11(4):29-34. PubMed ID: 1365487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee.
    Dick WC; Bulstra S; Schardijn GH; Feenstra RM
    Clin Ther; 1992; 14(4):517-26. PubMed ID: 1388092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers.
    Martínez L; Sánchez J; Roser R; García-Barbal J; Bartlett A; Estruch J; Sagarra R; Puig S; Costa A
    Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):729-37. PubMed ID: 3221746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events with droxicam in the early clinical trials.
    Sánchez J; Bartlett A; Costa A; Estruch J; Estiarte R; Soucheiron C
    Eur J Rheumatol Inflamm; 1991; 11(4):50-8. PubMed ID: 1365491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind randomised controlled trial of droxicam versus indomethacin in rheumatoid arthritis.
    Sánchez Andrada S; Rodríguez Valverde V
    Eur J Rheumatol Inflamm; 1991; 11(4):15-20. PubMed ID: 1365485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droxicam: a pharmacological and clinical review of a new NSAID.
    Jané F; Rodríguez de la Serna A
    Eur J Rheumatol Inflamm; 1991; 11(4):3-9. PubMed ID: 1365488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic profile of droxicam.
    Martínez L; Sánchez J
    Eur J Rheumatol Inflamm; 1991; 11(4):10-4. PubMed ID: 1365484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative double-blind study of droxicam (new NSAID) versus indomethacin in rheumatoid arthritis.
    Rodríguez-de-la-Serna A; Geli-Ferrer C; Diaz-López C; Sánchez-García J
    Eur J Rheumatol Inflamm; 1991; 11(4):35-44. PubMed ID: 1365489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piroxicam therapy: a double blind, randomized, multicenter study comparing 2 versus 4 week treatment in patients with painful knee osteoarthritis with effusion.
    Ravaud P; Auleley GR; Ayral X; Marre JP; Amor B
    J Rheumatol; 1998 Dec; 25(12):2425-31. PubMed ID: 9858440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis. Multicenter clinical trial].
    Consoli G; Covelli M; Di Matteo L; Marcolongo R; Tirri G; La Montagna G; Pipitone V
    Minerva Med; 1994 Mar; 85(3):89-96. PubMed ID: 8196849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis].
    Sigidin IaA; Pokryshkin VI
    Ter Arkh; 1987; 59(4):73-6. PubMed ID: 2954253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium.
    Selçuk E; Gomel M; Apaydin S; Köse T; Tuglular I
    Int J Clin Pharmacol Res; 1998; 18(1):21-9. PubMed ID: 9604731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of and tolerance to a new NSAID in the treatment of arthrosis: droxicam. Randomized study versus tenoxicam].
    Chevallard M; Venegoni C; Colombo B
    Minerva Med; 1993 Mar; 84(3):125-30. PubMed ID: 8492964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis.
    Kidd B; Frenzel W
    J Rheumatol; 1996 Sep; 23(9):1605-11. PubMed ID: 8877932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term evaluation of the treatment of osteoarthritis.
    Zizic TM; Sutton JD; Stevens MB
    Am J Med; 1986 Nov; 81(5B):29-35. PubMed ID: 3538868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endoscopic, histologic and morphometric evaluation of the gastric mucosa in patients with osteoarthritis treated with piroxicam and zinc acexamate].
    Guilarte López-Mañas J; Valenzuela Barranco M; Caballero Plasencia AM; Martín Ruiz JL
    Gastroenterol Hepatol; 1998 May; 21(5):212-7. PubMed ID: 9644873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience with the use of piroxicam in fast-dissolving sublingual capsules in acute recurrent osteoarthritis].
    Minisola G; Bancheri C; Bogliolo A; Brundisini B; Gospodinoff L; Lucentini L; Porzio F; Perpignano G
    Clin Ter; 1993 Dec; 143(6):519-29. PubMed ID: 8306576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
    Warrington S
    Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.